Oncology Central

Myelodysplastic/myeloproliferative neoplasms: a disease in need of recognition


Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) represent a unique subset of hematopoietic stem cell tumors characterized by clinical, morphologic and laboratory features of both MDS and MPN. According to the 2008 WHO classification, these myeloid neoplasms include four hematopathologic entities, namely chronic myelomonocytic leukemia (CMML), BCR–ABL1-negative atypical chronic myeloid leukemia, juvenile myelomonocytic leukemia (JMML) and MDS/MPNs unclassifiable (MDS/MPN-U) as well as a provisional entity of refractory anemia with ring sideroblasts and thrombocytosis (RARS-T).

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.